ATC Group: A01AB03 Chlorhexidine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A01AB03 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Stomatological preparations
3
Stomatological preparations
4
Antiinfectives and antiseptics for local oral treatment
5
A01AB03
Chlorhexidine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
30 mg

Active ingredients in A01AB03

Active Ingredient
Description

Chlorhexidine is an antimicrobial agent, active against a broad spectrum of Gram-positive and Gram-negative organisms, yeasts, fungi, opportunistic anaerobes and aerobes. Chlorhexidine is mainly a “membrane-acting” agent that destroys the outer membrane of the bacteria. It is inactive on bacterial spores unless the temperatures are high.

Medicines in this ATC group

Drug
Countries

Canada United States

Estonia Finland Hong Kong Ireland Netherlands ...

France Poland United States

Austria Ireland Singapore United States

Australia

Canada Ireland

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Structured Product Labeling (SPL)
US
Summary of Product Characteristics (SPC)
IE